Skip to main navigation Skip to search Skip to main content

Clarametyx 2021-02: Efficacy of CMTX-101 in the Murine Lung infection Model with Streptococcus pneumoniae

Project Details

StatusFinished
Effective start/end date11/01/21 → 10/01/22

Funding

  • Clarametyx Biosciences, Inc.: $30,129.10

Keywords

  • Biotechnology & Drug Development, Infectious Diseases